Figure 1. Combinatorial tetramers identify melanoma and viral-specific CD8+ T cells after neoadjuvant PD-1 blockade.

(A) Study schema with patient demographics and HLA types in neoadjuvant anti-PD-1 (nivolumab) clinical trial.
(B) Pathologic responses separated by complete response (pCR), near-complete response (pNCR), partial response (pPR), and non-response (pNR).
(C) Number of patients with melanoma and viral-specific CD8+ T cells, out of 32 HLA-A1, A2, and A3 patients.
(D) Representative flow plots of melanoma (red) and viral (blue)-specific CD8+ T cells identified by tetramers.
(E) Percentage of melanoma-specific CD8+ T cells in the blood, lymph node, and tumor. Each dot represents an individual tetramer+ population. The middle line and error bars indicate the mean ± SEM.
(F) Percentage of viral-specific CD8+ T cells in the blood, lymph node, and tumor. Each dot represents an individual tetramer+ population. The middle line and error bars indicate the mean ± SEM.
(G) Representative flow plots comparing CD39 and TIM-3 expressions on melanoma-specific CD8+ T cells and CD8+ T cells in the lymph node and tumor.
(H) PCA plot of melanoma-specific CD8+ T cells and CD8+ T cells in the lymph node and tumor. Each dot represents an individual population.
(I) Variables contributing to principal components.
(J) Representative flow plots comparing KI-67 and TCF-1 expressions on melanoma-specific CD8+ T cells in the blood, lymph node, and tumor.
(K) Representative flow plots comparing T-bet and TOX expressions on melanoma-specific CD8+ T cells in the blood, lymph node, and tumor.
(L) Expressions of selected markers on melanoma-specific CD8+ T cells in the blood, lymph node, and tumor. Each line connects paired samples from the same patient. Thick line with dots indicates the group mean.
Statistical significance was assessed using the Wilcoxon rank-sum test for unpaired comparisons and the Wilcoxon signed-rank test for paired comparisons. P-values are reported as follows: ns (not significant), *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.
See also Figures S1–S3 and Tables S1–S3.